A single type of stem cell builds the spinal cord, vertebrae, and muscles of the developing embryo, then vanishes completely once its job is done. These cells, called neuromesodermal (NM) progenitors, are unusual because they produce two distinct tissue types—nervous tissue and muscle, bone, and cartilage—unlike most stem cells, which are restricted to one. The researchers have already grown NM-like cells in a dish and now want to understand how the embryo creates them, how they decide which tissue to make, and crucially, how the embryo knows when to eliminate them. This elimination step matters because several human birth defects, including caudal regression syndrome (a condition more common in babies of diabetic mothers), may result from NM progenitors not being properly removed. The work is fundamental developmental biology, not a therapy trial. However, NM progenitors do not form malignant tumours when injected into adult mice, unlike embryonic stem cells, making them a promising future source of transplantable muscle, bone, or spinal cord tissue. Understanding their natural life cycle could also reveal why certain developmental abnormalities occur.
View original technical description
During embryo development, the spinal cord, vertebral column and muscles are laid down by stem cells. We have shown that these stem cells are unique for several reasons. Unlike embryonic stem (ES) cells, which can make any tissue in the body, or neural stem cells, which only make nervous tissue, these 'neuromesodermal' or 'NM' progenitors make two very distinct embryonic tissue types, the neural tube (which then generates spinal cord) and the mesoderm (which makes muscle, bone and cartilage). These stem cells are born very early during development and are active until the precursors of spinal cord and vertebral column are laid down. They then are completely removed from the embryo. These cells would be a useful source of differentiated muscle, bone, and spinal cord if we could grow them in a culture dish. In fact, unlike ES cells, NM progenitors do not make malignant tumours when injected in adult mice. Recently, we have generated, in cell culture, NM progenitor-like cells and we plan to study how these cells are generated, how they make neural tube and mesodermal cell types, and how the embryo knows when to eliminate them. Several human birth abnormalities including caudal regression syndrome, a high risk for diabetic mothers, may arise because NM progenitors are not correctly eliminated, and we will use our knowledge of NM progenitors in the embryo to study whether this is the case. This programme therefore combines study of cells in embryos with cells in culture to understand development and disease, and to produce cell types that may be useful in the future for cell therapies.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know